Volitionrx (VNRX) EPS (Diluted) Growth (3y) (2021 - 2025)
Volitionrx (VNRX) EPS (Diluted) Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 63.42% |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 29.56% |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 30.57% |
| 10 | Volitionrx | 92,271.21 | -1.02 Mn | - | 26.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.12% |
| Sep 30, 2025 | 91.22% |
| Jun 30, 2025 | -59.99% |
| Mar 31, 2025 | -147.77% |
| Dec 31, 2024 | 46.83% |
| Sep 30, 2024 | 44.88% |
| Jun 30, 2024 | -224.18% |
| Mar 31, 2024 | -482.32% |
| Dec 31, 2023 | -355.70% |
| Sep 30, 2023 | -913.74% |
| Jun 30, 2023 | -1,079.48% |
| Mar 31, 2023 | -14.82% |
| Dec 31, 2022 | -24.95% |
| Sep 30, 2022 | -22.19% |
| Jun 30, 2022 | 26.40% |
| Mar 31, 2022 | 26.42% |
| Dec 31, 2021 | -25.49% |
| Sep 30, 2021 | -16.82% |
| Jun 30, 2021 | 26.21% |